Aflibercept trial is a milestone for patients with metastatic colorectal cancer

Authors

George P. Kim, Mayo Clinic in Jacksonville, Florida

Document Type

Journal Article

Publication Date

4-1-2012

Journal

Community Oncology

Volume

9

Issue

4

DOI

10.1016/j.cmonc.2012.03.009

APA Citation

Kim, G. (2012). Aflibercept trial is a milestone for patients with metastatic colorectal cancer. Community Oncology, 9 (4). http://dx.doi.org/10.1016/j.cmonc.2012.03.009